Metabolic disorders, while primarily endocrine in nature, can have significant psychiatric implications. From mood disturbances due to thyroid disorders to cognitive challenges in diabetes, understanding the broader impact is vital. The Journal of Clinical Psychiatry provides insights into the psychiatric aspects of metabolic disorders, emphasizing evidence-based therapeutic approaches. Our expert editors ensure content is actionable and holistic, aiding psychiatrists in offering comprehensive care.
Metabolic Disorders
Page 4
Recently published articles about Metabolic Disorders
Article
Aripiprazole Partial Agonism at 5-HT2C: A Comparison of Weight Gain Associated With Aripiprazole Adjunctive to Antidepressants With High Versus Low Serotonergic Activities
October 18, 2012
Aripiprazole is a partial agonist at several receptor sites, one of which is 5-HT2C, which has been associated with increased food intake. The authors of this study theorize that...
Article
Antipsychotic Adherence and Its Correlation to Health Outcomes for Chronic Comorbid Conditions
June 21, 2012
The authors of this study examine the relationship between adherence to antipsychotics and adherence to medications for cardiometabolic conditions (diabetes, hypertension, and hyperlipidemia) and subsequent health care utilization and...
Letter to the Editor
Severe Weight Gain With Long-Acting Injectable Risperidone: A Case Report
August 12, 2010
Weight gain is a major problem with second-generation antipsychotics. Here, delve into the case of a patient diagnosed with schizophrenia, catatonic type, who gained 84 lb during 14 months...
